Depression is an Alzheimer's Risk Factor
Posted on: Tuesday, 8 April 2008, 12:00 CDT
Depression is a risk factor for Alzheimer's disease rather than a subtle early sign of its underlying pathology, a U.S. study suggests.
Researchers analyzed data from the Rush Religious Orders Study, a cohort of 917 older Catholic clergy without dementia at study onset. Study participants were tracked for 13 years and 190 developed Alzheimer's disease.
The study, published in the Archives of General Psychiatry, found, consistent with earlier findings, having more depressive symptoms at baseline was associated with increased incidence of Alzheimer's disease and mild cognitive impairment.
Robert S. Wilson, a neuropsychologist at the Rush University Medical Center's Alzheimer's Disease Center and colleagues, say those who developed Alzheimer's disease showed no increase in depressive symptoms before clinical diagnosis.
Depressive symptoms may be associated with distinctive changes in the brain that somehow reduce neural reserve, which is the brain's ability to tolerate the pathology associated with Alzheimer's disease, Wilson said in a statement.
Source: United Press International
Related Articles
- Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets
- Epix Initiates Second Trial in Phase IIb Alzheimer's Disease Study
- Kurve Technology Achieves Clinical Success in Alzheimer's Disease Study
- Medivation's Dimebon Meets All Five Efficacy Endpoints in Phase 2 Alzheimer's Disease Study; Conference Call Begins at 1:00 P.M. Eastern Time Today
- Stress Hastens Progression of Alzheimer's Disease - Study
- New Study of Depressive Symptoms in Parkinson's Disease Patients Shows Positive Results for Mirapex
- Novel Approach May Offer New Hope to Women With Alzheimer's Disease, Study Shows
- Increase in Specific, Abnormal Brain Protein May Predict Onset of Alzheimer's Disease, Study Shows
- Green Tea Ingredient Protects Brain Against Alzheimer's Disease: Study
- Cortex Commences Enrollment in Two Additional Phase IIa Studies With AMPAKINE CX717; ADHD and Alzheimer's Disease Studies Are Underway
User Comments (0)

RSS Feeds